Document is current
Any future updates will be listed below
-
Authors
Li, Ting
Li, Xinyuan
Zamani, Ali
Wang, Wei
Lee, Chin-Nien
Li, Mingyue
Luo, George
Eiler, Emily
Sun, Honghong
Ghosh, Sankar
Jin, Jian https://orcid.org/0000-0002-2387-3862
Murali, Ramachandran
Ruan, Qingguo
Shi, Weiyun
Chen, Youhai H. https://orcid.org/0000-0002-9695-6757
-
Funding
Funding for this research was provided by:
National Institutes of Health (NIH), USA
- License Information
-
More Information
Article History
Received: 24 June 2019
Accepted: 31 March 2020
First Online: 18 May 2020
Competing interests
: Y.H.C. and R.M. are inventors of the following patent that describes the c-Rel inhibitor used in this study: Chen Y.H., Murali R. & Sun J. Rel inhibitors and methods of use thereof (USA patent no. US8609730B2). Y.H.C. is a member of the advisory board of Amshenn Pharmaceutical Company and Binde Company.
